SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-027267
Filing Date
2022-11-14
Accepted
2022-11-14 16:10:07
Documents
15
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20221111_8k.htm   iXBRL 8-K 23376
2 EXHIBIT 99.1 ex_446432.htm EX-99.1 159207
7 a01.jpg GRAPHIC 5524
  Complete submission text file 0001437749-22-027267.txt   336810

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20221114.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20221114_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20221114_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20221114_pre.xml EX-101.PRE 11689
9 EXTRACTED XBRL INSTANCE DOCUMENT acrx20221111_8k_htm.xml XML 2574
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 221385275
SIC: 2834 Pharmaceutical Preparations